The Medicines Company (MDCO)
(Delayed Data from NSDQ)
$31.89 USD
+0.61 (1.95%)
Updated May 3, 2019 04:00 PM ET
After-Market: $31.90 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[MDCO]
Reports for Purchase
Showing records 1 - 20 ( 239 total )
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Got Its Christmas Wish Granted Early With Novartis Takeout
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Another Triumph at AHA with ORION-9 - Our Comparative Analysis
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
ORION-10 Is out of the Bag - It Is Another Lion
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
Get a Head Start on AHA in Philadelphia with Our Prep Material
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
Healthcare - Earnings Recap: Halftime Show of Our Most In-Depth, Differentiated Earnings Yet
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Trick or Treat ahead of AHA: Treat With Our Day-by Day Calendar
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
3Q19 - Yas''s Take On Investors'' Top Five MDCO Questions
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Don''t Judge the Inclisiran Book Before Reading It
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department